Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Clear, empathetic diagnosis guidance for people with functional neurological movement disorders

Official title: The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intentions in Patients With Functional Neurological Movement Disorders: An Intervention Study Using a Within-Subject Design

Run by Medical University of Graz · NCT07588282 · Data updated 2026-11-12

This study tests whether a structured, empathetic explanation of the diagnosis helps patients with functional neurological movement disorders understand their condition and feel more satisfied with care.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment35 (estimated)
SponsorMedical University of Graz
Academic / other
Locations1 site (Graz)
StatusRecruiting
StartedMarch 31, 2026
Main results expectedJuly 31, 2027
Study endsDecember 31, 2027
Registry record updatedMay 14, 2026
Trial IDNCT07588282 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with one or more functional movement disorders (e.g., functional paralysis, seizures, tremor, dystonia, tics, or related symptoms) who can provide informed consent and understand German.

Probably not a fit

Patients who are not responsive to psychoeducational messaging or who have barriers to implementing the information during care may receive little benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines if providing a psychoeducational, guideline-based explanation of a Functional Neurological Movement Disorder diagnosis during a routine clinic visit improves patients' understanding and experiences of their symptoms and care. Participants will receive a one-time psychoeducational communication guide during their consultation, with brain MRI performed as part of the protocol to explore related brain function. The study also looks at patient and clinician perspectives on the diagnostic conversation and its impact on treatment willingness and symptom perception. The primary focus is on first-diagnosis communication and its potential to enhance engagement and clarity in management. Conducted at the Medical University of Graz, the trial includes adults with a range of functional movement disorder presentations and requires German proficiency for questionnaire completion.

Why it matters

Potential benefit: If successful, patients may better understand their diagnosis, feel more satisfied with their care, and be more open to treatment options.

How similar studies have gone: Prior psychoeducational approaches have shown positive effects, though mainly in group programs; this study tests an individual, clinic-based format.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Presence of any of the following functional movement disorders:

  * Functional paralysis
  * Functional seizures
  * Functional tremor
  * Functional drop attacks
  * Functional dystonia
  * Functional twitching
  * Functional facial symptoms
  * Functional tics
  * Functional parkinsonism

Exclusion Criteria:

* The patient is unable to give informed consent.
* The patient is temporarily unable to give informed consent.
* The patient does not have sufficiently understand German language to answer the questionnaires (the questionnaires are available only in German).

Where it's running

  • Medical University of Graz
    Graz, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.